| Literature DB >> 35164011 |
Jing Lu1,2,3,4,5, Yu Zhao1,4, Yu Cheng1,4, Rong Hu1,4, Yaowei Fang1,3,4,5, MingSheng Lyu1,3,4,5, Shujun Wang1,3,4,5, Zhaoxin Lu2.
Abstract
Acetaldehyde dehydrogenases are potential enzyme preparations that can be used to detoxify acetaldehyde and other exogenous aldehydes from pharmaceuticals, food, and biofuel production. In this study, we enhanced the expression of acetaldehyde dehydrogenase sourced from Issatchenkia terricola (istALDH) in Bacillus subtilis using a combinatorial strategy for the optimization of signal peptides, promoters, and growth conditions. First, a library of various signal peptides was constructed to identify the optimal signal peptides for efficient istALDH secretion. The signal peptide yqzG achieved the highest extracellular istALDH activity (204.85 ± 3.31 U/mL). Second, the aprE promoter was replaced by a constitutive promoter (i.e., P43) and an inducible promoter (i.e., Pglv), resulting in 12.40% and 19.97% enhanced istALDH, respectively. Furthermore, the tandem promoter P43-Pglv provided a better performance, resulting in 30.96% enhanced istALDH activity. Third, the production of istALDH was optimized by testing one factor at a time. Physical parameters were optimized including the inducer (e.g., maltose) concentrations, incubation temperatures, and inoculation amounts, and the results were 2.0%, 35 ∘C, and 2.0%, respectively. The optimized medium results were 2.0% glucose, 1.5% peptone, 2.5% yeast extract, 1% NaCl, and 0.5% (NH4)2SO4. The extracellular istALDH activity was 331.19 ± 4.19 U/mL, yielding the highest production reported in the literature to date.Entities:
Keywords: Bacillus subtilis; acetaldehyde dehydrogenase; optimization of fermentation; signal peptide; tandem promoter
Mesh:
Substances:
Year: 2022 PMID: 35164011 PMCID: PMC8838704 DOI: 10.3390/molecules27030747
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Bacterial strains and plasmids used in this study.
| Strains/Plasmids | Characteristics * | Source |
|---|---|---|
| Strains | ||
| deoR endA1 gyrA96 hsdR17 (rk-mk+)recA1 relA1 supE44 thi-1 Δ(lacZYA-argF)U169 Φ80lacZ ΔM15F-λ- | Vazyme Biotech | |
| Marburg 168 derivative; trpC2, lys1, aprEΔ3, nprR2, nprE18 | Takara | |
| derived from | laboratory stock | |
| BS-1 | RIK1285 harboring pBE/istALDH | current study |
| BS-2 | RIK1285 harboring pBE/istALDH-1 | current study |
| BS-3 | RIK1285 harboring pPglv/istALDH | current study |
| BS-4 | RIK1285 harboring pP43/istALDH | current study |
| BS-5 | RIK1285 harboring p P43-Pglv /ist-ALDH | current study |
| BS-6 | RIK1285 harboring p Pglv-P43/ist-ALDH | current study |
| Plasmid | ||
| pMD19T | TA clon vector, Amp+ | Takara |
| pHCMC04-pPglv | Pglv promoter | [ |
| pPSQ | P43 promoter | [ |
| pET32a/istALDH | istALDH | [ |
| pBE | Kan+, Amp+, PaprE, SPaprE | Takara |
| pBE/istALDH | Kan+, Amp+, PaprE, SPaprE, istALDH | current study |
| pBE/istALDH-1 | Kan+, Amp+, PaprE, SPyqzG, istALDH | current study |
| pPglv/istALDH | Kan+, Amp+, Pglv, SPyqzG, istALDH | current study |
| pP43/istALDH | Kan+, Amp+, P43, SPyqzG, istALDH | current study |
| pP43-Pglv/istALDH | Kan+, Amp+, P43-Pglv, SPyqzG, istALDH | current study |
| pPglv-P43/istALDH | Kan+, Amp+, Pglv-P43, SPyqzG, istALDH | current study |
* Amp+ and Kan+ indicate resistance to ampicillin and kanamycin, respectively.
Primers used in this study.
| Primer | Sequence (5′ to 3′) |
|---|---|
| P1 | GAGCTCCTTAGAACTGCAACTAGAAC |
| P2 | GGATCCTTGTGGGCCATCGTTAATGGC |
| P3 | CGCGTCCCTCTCCTTTTGCTTAAGTTCAGAGTAG |
| P4 | GGCCGGTGCACATATGGAGCTCCTTAGAACTGC |
| P5 | GCCGTCTGTACGTTCCTAAACTAGTGGCATGTATCCGAATC |
| P6 | GTTTGATCATCATACGCGTACGACCTCCTTGATAACG |
| P7 | ATGATGATCAAACAATGTGTGATTTGTC |
| P8 | TTAGGAACGTACAGACGGCTTAAAAG |
| P9 | CTTTTAAGCCGTCTGTACGTTCCTAAACTAGTATATTCCTTTTGATAGGTGG |
| P10 | GACAAATCACACATTGTTTGATCATCATACGCGTATTCCTCTCTTACCTATAATG |
| P11 | GCCGTCTGTACGTTCCTAAACTAGTATATTCCTTTTGATAGGTGGTATG |
| P12 | CTTTTGTACGATTCGGATACATGCCACTAGTATTCCTCTCTTACCTATA |
| P13 | GGCATGTATCCGAATCGTACAAAAG |
| P14 | ACTAGTTTAGGAACGTACAGACGGCTTAAAAG |
| P15 | CTTTTAAGCCGTCTGTACGTTCCTAAACTAGTGGCATGTATCCGAATC |
| P16 | CCACCTATCAAAAGGAATATACTAGTACGACCTCCTTGATAACG |
| ALDH-RT-F | CAGAGGTGAGCACTTGATGAAAC |
| ALDH-RT-F | CAGCCCAACCAGCACAATACTTA |
| 16S rRNA-F | ACGGGAGGCAGCAGTAGGG |
| 16S rRNA-R | ACGGGAGGCAGCAGTAGGG |
Figure 1(a) The recombinant istALDH activity and growth curve of B. subtilis RIK 1285 harboring pBE/istALDH. (b) SDS-PAGE analysis of expression products for the recombinant istALDH at the fermentation supernatant expected molecular mass of 57 k Da (indicated by the black arrow). Lane M is the molecular mass marker (26610, Thermo). Lane 1 (negative control) is the fermentation supernatant of RIK 1285 harboring pBE. Lanes 2 is the fermentation supernatant of RIK 1285 harboring pBE/istALDH. The experimental data were expressed as means ± standard deviations (SDs) of at least three independent experiments.
Efficiency of different SPs in istALDH secretion.
| Signal Peptide | Protein Sequence | Len | D-Score a | Charge b | Hydrophilicity c (%) | Activity of istALDH d |
|---|---|---|---|---|---|---|
| yqzG | MMIKQCVICLSLLVFGTTAAHA | 22 | 0.716 | 1 | 63.64 | 204.85 ± 3.31 |
| wapA | MKKRKRRNFKRFIAAFLVLALMISLVPADVLA | 32 | 0.707 | 7 | 65.63 | 184.81 ± 3.59 |
| yngK | MKVCQKSIVRFLVSLIIGTFVISVPFMANA | 30 | 0.677 | 3 | 66.67 | 160.76 ± 3.86 |
| xynA | MFKFKKNFLVGLSAALMSISLFSATASA | 28 | 0.757 | 1 | 64.29 | 147.84 ± 2.90 |
| pbp | MKKSIKLYVAVLLLFVVASVPYMHQAALA | 29 | 0.672 | 3 | 68.97 | 140.20 ± 3.52 |
| aprE | MRSKKLWISLLFALTLIFTMAFSNMSVQA | 29 | 0.644 | 3 | 62.07 | 113.71 ± 3.62 |
a D-score calculated using Signal P 4.1. b Charge of the SP was calculated based on D and E counted as −1, R; K as +1; and any other amino acid as 0. c Percentage of hydrophobic amino acids in each signal sequence was calculated according to G, A, V, L, I, M, F, W, and P as hydrophobic amino acids, whereas all others were hydrophilic. d Values represent extracellular istALDH activity ± SD based on three independent results.
Figure 2The intracellular (a) and extracellular (b) istALDH activities, and the relative expression of istALDH (c) of recombinant B. subtilis strains with different promoters. The experimental data were expressed as means ± standard deviations (SDs) of at least three independent experiments.
Figure 3The istALDH activity of recombinant B. subtilis strains with tandem promoters. The experimental data were expressed as means ± standard deviations (SDs) of at least three independent experiments.
Different combinations of peptone and yeast extract.
| g/L | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
|---|---|---|---|---|---|---|---|
| Peptone | 0 | 10 | 15 | 20 | 25 | 30 | 40 |
| Yeast extract | 40 | 30 | 25 | 20 | 15 | 10 | 0 |
Figure 4Optimization of culture conditions and medium composition of B. subtilis-5. (a) Temperature, (b) inoculum amount, (c) glucose, (d) NH4)2SO4, (e) maltose, (f) organic nitrogen source. The experimental data were expressed as means ± standard deviations (SDs) of at least three independent experiments.